Abstract bekijken

Deze abstract is toegekend aan sessies
Type presentatieOral presentation
TitelDriving Forces and Perceived Barriers for the Adoption of Novel Endothelial Cell Therapies: An International Survey of Corneal Surgeons
DoelTo evaluate corneal transplant surgeons’ current practice pattern and their interest and adoption attitudes toward novel endothelial cell replacement via an online survey.
MethodesThe online survey contained 25 questions (13 single-choice, 12 multi-choice) separated in the 4 sections “General Demographics and Practice Patterns,” “New Corneal Endothelial Cell Replacement Therapies,” “Perceived Barriers,” and “Surgeon Perspectives on Graft Design for Tissue-Engineered Endothelial Grafts.” A total of 116 responses were evaluated.
ResultatenMost respondents (97.4%, n = 113) would consider the adoption of novel, commercially available cell replacement therapies in the future. Ease of surgical handling, better clinical outcomes, and donor tissue shortages were seen as the main driving forces for adoption. Although being acknowledged as an easier procedure, most respondents expressed that cell injection should be restricted to corneal specialists and not be performed by comprehensive ophthalmologists.
ConclusieThe survey shows a positive attitude for adopting new endothelial cell replacement therapies among corneal surgeons. Perceived barriers and expected training requirements for the clinical adoption of the new therapies were identified and should be addressed to ensure a successful clinical translation.
BelangenverstrengelingNee
Auteurs 1
NaamLUAN
InitialenY
InstituutVrije Universiteit Brussel (VUB),Universitair Ziekenhuis Brussel (UZB)
StadBrussels
Auteurs 2
NaamNí Dhubhghaill
InitialenS
InstituutDepartment of Ophthalmology, UZ Brussel / Vrije Universiteit Brussel (VUB)
StadBrussels
Auteurs 3
NaamRose-Nussbaumer
InitialenJ
InstituutByers Eye Institute, Department of Ophthalmology, Stanford University
StadPalo Alto
Auteurs 4
Naamde Kort
InitialenC
InstituutNetherlands Institute for Innovative Ocular Surgery
StadRotterdam
Auteurs 5
NaamRomano
InitialenV
InstituutEye Unit, University of Brescia
StadBrescia
Auteurs 6
NaamOellerich
InitialenS
InstituutDepartment of Ophthalmology, UZ Brussel / Vrije Universiteit Brussel (VUB)
StadBrussels
top ^